Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
71.90
-1.61 (-2.19%)
At close: Mar 13, 2026, 4:00 PM EDT
72.40
+0.50 (0.70%)
Pre-market: Mar 16, 2026, 5:11 AM EDT
Apogee Therapeutics Employees
Apogee Therapeutics had 261 employees as of December 31, 2025. The number of employees increased by 65 or 33.16% compared to the previous year.
Employees
261
Change (1Y)
65
Growth (1Y)
33.16%
Revenue / Employee
n/a
Profits / Employee
-$980,241
Market Cap
5.00B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 261 | 65 | 33.16% |
| Dec 31, 2024 | 196 | 105 | 115.38% |
| Dec 31, 2023 | 91 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| PTC Therapeutics | 991 |
| Amicus Therapeutics | 511 |
| CRISPR Therapeutics AG | 393 |
| Mirum Pharmaceuticals | 372 |
| Xenon Pharmaceuticals | 370 |
| Immunovant | 362 |
| Scholar Rock Holding | 289 |
APGE News
- 13 days ago - Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results - GlobeNewsWire
- 19 days ago - Apogee Therapeutics to Participate in Upcoming March Conferences - GlobeNewsWire
- 5 weeks ago - Apogee Therapeutics to Participate at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 7 weeks ago - Apogee Therapeutics: 2026 Inflection Point In Immunology - Seeking Alpha
- 2 months ago - Apogee Therapeutics, Inc. (APGE) Discusses Interim Phase Ib Results of Zumilokibart for Mild-to-Moderate Asthma and Pipeline Developments Transcript - Seeking Alpha
- 2 months ago - Apogee Therapeutics Announces Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777), its Potentially Best-in-Class Anti-IL-13 Antibody, in Patients with Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and Outlook - GlobeNewsWire
- 2 months ago - Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1b Trial of APG777 in Patients with Mild-to-Moderate Asthma and 2026 Anticipated Milestones on January 6, 2026 - GlobeNewsWire
- 3 months ago - Apogee Therapeutics, Inc. (APGE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha